Regulatory Approval

PorTal Access wins FDA clearance for FLEXI-PORT™, a device poised to disrupt a stagnant market by focusing on patient comfort and clinical versatility.

Lincoln Gold's Bell Mountain project is nearing construction, set to trigger a lucrative 3% royalty for Globex in a gold market far hotter than projections.

By securing crucial FEOC compliance, NeoVolta's new Georgia battery factory unlocks major tax credits and positions itself as a key supplier in America's energy race.

With regulatory approval for its $218M deal, Firm Capital deepens its push into manufactured housing, a key affordable housing segment in Western Canada.

Masimo's FDA-cleared AI monitor for opioid risk does more than track vitals; it predicts danger, pushing healthcare from reactive alarms to proactive intervention.

GuideAI Health's new AI software, which scans for peripheral vascular disease, promises to slash diagnosis times and prevent amputations for millions.

With FDA clearance for its first-in-class remyelination drug, Scottish biotech Pheno Therapeutics is moving beyond inflammation to repair neurological damage.

A bold federal mandate pushes to optimize our underused power grid. Can smarter tech solve the energy bottleneck and save billions without raising your bill?

Leading Edge Materials holds Europe's rare earth keys, but a 'going concern' warning reveals a critical flaw in the continent's resource strategy.

With dual Leica lenses, a triple AI chip, and 8K video, the Insta360 Luna Ultra isn't just an upgrade—it's a paradigm shift for content creators.

A strategic pharma alliance scores a major win in Japan's lucrative neurology market, signaling a new competitive front and hope for thousands of patients.

A prestigious award for its ASD therapy Speragen puts Korean biotech Astrogen in the spotlight. Now, the firm faces the gauntlet of regulatory approval and market entry.

A new platform aims to give retail investors institutional-grade AI trading tools. But as it democratizes access, can it manage the inherent risks of crypto?

Kardium’s landmark FDA win and a new wave of innovators signal a biotech boom, cementing British Columbia's status as a global hub for health innovation.

As banking giants merge, United Development Bank secures FDIC approval to launch a new community-focused institution in Bellevue, betting on relationship banking and financial inclusion.

Utah's Co-Diagnostics is transferring its AI-powered diagnostic platform to a Saudi JV. It's a bold move to crack a booming market and a critical test of its strategy.

BioCardia bets its future on Japan's fast-track approval for its heart therapy, a strategic pivot that could unlock global markets or break the bank.

A new report reveals a startling trend: as AI adoption soars, financial firms are increasingly banning communication channels, a defensive move creating new risks.

As new regulations unleash a flood of bond market data, MarketAxess's TraX Tape uses AI and a decade of refinement to turn chaos into actionable intelligence.

Merck secures a pivotal FDA approval for its CAPVAXIVE vaccine, offering new hope for at-risk youth and challenging rivals in the high-stakes pneumococcal market.